Please assess the completion status of the following clinical trial:

Trial Title: Nitrous Oxide for Pain Management During In-Office Gynecology Procedures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Negative UPT~* English speaking,~* At the Banner Women's Institute who are consented for any of the following procedures with sedation: Diagnostic hysteroscopy, Hysteroscopic endometrial biopsy, Hysteroscopy, IUD placement, Hysteroscopic IUD removal, Colposcopy, LEEP~Exclusion Criteria:~* Chronic narcotic use,~* Contraindications to Nitrous oxide (i.e. Vit B12 deficiency, pulmonary disease),~* Indication for general anesthesia in the main operating room~* BMI \>40~* Non-English Speaking

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: t

Study Arms:
- Nitrous Day (Type: EXPERIMENTAL): The Nitrous group will receive instructions to arrive at clinic 30 minutes before her procedure in order to sign consent forms. She will not be given instructions to remain NPO and will not be required to have someone bring her to and from the appointment. No IV will be placed. Anesthesia induction will be done by an anesthesiologist with a nitrous oxygen mixture at a 70:30 ratio
- IV Sedation Day (Type: ACTIVE_COMPARATOR): The IV sedation group will receive instructions to arrive at clinic 1 hour before her procedure in order to sign consent forms and have an IV placed. She will be given instructions to remain NPO status at least 8 hours prior to the procedure and will need someone to bring her to and from the appointment. Anesthesia induction will be done by an anesthesiologist with propofol per standard protocol.

Based on this trial design, predict the completion outcome and termination type (if applicable).